Related Experiment Videos
Chronomodulated chemotherapy and irradiation: an idea whose time has come?
Tyvin A Rich1, Charles H Shelton, Alexander Kirichenko
1Department of Radiation Oncology, University of Virginia Health System, Charlottesville 22908, USA. tar4d@virginia.edu
Chronobiology International
|April 19, 2002
Summary
Chronomodulated chemotherapy delivery times cancer treatments to spare normal tissues, improving tolerance and efficacy. This approach leverages circadian rhythms in cell proliferation for better outcomes in chemoradiation therapy.
Area of Science:
- Oncology
- Chronobiology
- Pharmacology
Background:
- Circadian variations exist in normal tissue proliferative activity, influencing response to chemotherapy.
- Technological advancements enable precise, timed drug delivery for cancer treatment.
- Understanding chronobiology and chronopharmacology is key to optimizing chemotherapy.
Purpose of the Study:
- To review evidence for chronomodulated chemotherapy delivery in cancer treatment.
- To explore the concept of chronotolerance in normal tissues.
- To highlight the application of chronomodulation in chemoradiation therapy.
Main Methods:
- Review of laboratory and clinical evidence on chronomodulated chemotherapy.
- Focus on S-phase chemotherapeutic agents like 5-fluorouracil (5-FU) and camptothecin.
- Examination of chronopharmacologic behavior and chronotolerance.
Main Results:
- Chronomodulated administration of S-phase agents can spare normal tissues like gut and bone marrow.
- Evidence supports chronomodulated 5-FU and camptothecin for better biological tolerance.
- Emerging clinical data suggests this approach is effective in chemoradiation.
Conclusions:
- Precise timing of systemic chemotherapeutic radiosensitizers can reduce toxicity.
- Optimizing drug delivery schedules maximizes treatment effects in chemoradiation.
- Further studies are needed to refine chronomodulated chemoradiation protocols.